Bausch Site 103 — Denver, Colorado

Bausch Site 103 is a clinical research site located in Denver, Colorado, United States 80220.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Bausch Site 103 has participated in 1 clinical trials.

Therapeutic areas: Sickle Cell Disease.

Sponsors: Bausch Health Americas, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Denver

Browse all research sites in Colorado · View every site in Denver

• Cancer Centers of Colorado at Saint Joseph Hospital
• Centura Health Porter Adventist Hospital
• University of Colorado Denver Health Sciences
• The Childrens Hospital
• Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
• University of Colorado Denver /ID# 233676
• University of Colorado Cancer Center
• Project Safe, University of Colorado
• National Jewish Health, University of Colorado Denver
• Regents of the University of Colorado
• University of Colorado Cancer Center at UC Health Sciences Center
• Denver Health and Hospitals

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Bausch Site 103?

Bausch Site 103 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Bausch Site 103 conducted?

Bausch Site 103 has 1 clinical trials on record. Their work covers Sickle Cell Disease.

Is Bausch Site 103 accredited by Crixeo Clinical Trials?

Bausch Site 103 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Bausch Site 103?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.